Keywords: diuresis; furosemide; heart failure; pharmacokinetics; subcutaneous; ANOVA; analysis of variance; AUC; area under the curve; AUCâ; plasma concentration to infinity; AUClast; last measurable plasma concentration; CI; confidence interval; Cmax; peak plasm
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: kidney; hydronephrosis; congenital; radioisotope renography; diuresis; AUC; area under the curve; C30; clearance at 30 minutes; CH; congenital hydronephrosis; CUP; clearance with patient upright; DR; diuretic renography; MAG-3; 99mTc-mercaptoacetyltriglyc
Pharmacokinetics of human recombinant C1-esterase inhibitor and development of anti-drug antibodies in healthy dogs
Keywords: AUC; area under the curve; AUClast; area under the plasma concentration-time curve from the time of dosing to the last measurable (positive) concentration; AUC-INFobs; area under the plasma concentration-time curve from the time of dosing extrapolated to
The influence of microplastics and halogenated contaminants in feed on toxicokinetics and gene expression in European seabass (Dicentrarchus labrax)
Keywords: α; assimilation efficiency; α-HBCD; α-hexabromocyclododecane; BFR; brominated flame retardant; Ccontrol feed; contaminant concentration in control feed; Cfeed; contaminant concentration in feed; Cfish; contaminant concentration in fish fillet; cyp1
Pharmacokinetics and safety of a single dose of the novel LAMA/LABA fixed-dose combination of glycopyrronium/formoterol fumarate dihydrate metered dose inhaler, formulated using co-suspension delivery technology, in Japanese healthy subjects
Keywords: GFF MDI; Chronic obstructive pulmonary disease; Co-suspension delivery technology; LAMA/LABA; Pharmacokinetics; AE; adverse event; AUC0-12; area under the curve from 0 to 12â¯h; AUC0-t; area under the curve from 0 to time of the last measurable plasm
Safety and pharmacokinetics of budesonide/glycopyrronium/formoterol fumarate dihydrate metered dose inhaler (BGF MDI) in healthy adult subjects of Japanese descent
Keywords: Chronic obstructive pulmonary disease; Co-suspension delivery technology; ICS/LAMA/LABA; Western; Japanese; Triple fixed-dose combination; AE; adverse event; AUC0-12; area under the plasma concentration-time curve from 0 to 12â¯h; AUC0-â; area un
Pharmacokinetics and pharmacodynamics of a buprenorphine subcutaneous depot formulation (CAM2038) for once-weekly dosing in patients with opioid use disorder
Keywords: AUC0-7d; area under the concentration-time curve from time of dosing to 7Â days; AUC0-last; area under the concentration-time curve from time zero to last observed concentration; AUC0-â; Â area under the concentration-time curve from time ze
Pharmacological preclinical characterization of LAS190792, a novel inhaled bifunctional muscarinic receptor antagonist /β2-adrenoceptor agonist (MABA) molecule
Keywords: COPD; Bronchodilator; Long-acting β2-adrenoceptor agonist; Long-acting muscarinic antagonist; ACh; acetylcholine; ANOVA; analysis of variance; β; beta-adrenoceptor; cAMP; cyclic adenosine monophosphate; CHO; Chinese hamster ovary; CI; confidence interva
Original articleUse of fibrin glue as a sealant at the anastomotic line in laparoscopic pyeloplasty: A randomised controlled trial
Keywords: CONSORT; Consolidated Standards of Reporting Trials; DTPA; diethylene-triamine-penta-acetic acid; LPP; laparoscopic pyeloplasty; PUJO; PUJ obstruction; T½; clearance half-time (renogram); Laparoscopic pyeloplasty; Fibrin glue; PUJ obstruction; Stentless
Pharmacologic inhibition of small-conductance calcium-activated potassium (SK) channels by NS8593 reveals atrial antiarrhythmic potential in horses
Keywords: aEGM; intra-atrial electrogram; aERP; atrial effective refractory period; AF; atrial fibrillation; ANOVA; analysis of variance; APD; action potential duration; cDNA; complementary DNA; dV/dtmax; maximum upstroke velocity; HR; heart rate; IV; intravenous;
Target-mediated clearance and bio-distribution of a monoclonal antibody against the Kunitz-type protease inhibitor 2 domain of Tissue Factor Pathway Inhibitor
Keywords: AUC; area under the curve; Cl; clearance; DAB; 3,3â²-diaminobenzidine; dIF; double immunofluorescence; EGFR; epidermal growth factor receptor; GAG; glycosaminoglycans; GPI; glycosylphosphatidylinositol; FVIII; Factor VIII; FIX; Factor IX; FXa; Factor Xa;
The fate of inhaled 14C-labeled PCB11 and its metabolites in vivo
Keywords: BW; body weight; CYP; cytochrome P450; GI; gastrointestinal; MeSO2; methylsulfonyl; OH-PCB; hydroxylated polychlorinated biphenyl; PCB; polychlorinated biphenyl; t½; biological half-life; Biodistribution; Polychlorinated biphenyl; Inhalation; Persistent
Increased volume of distribution for recombinant activated factor VII and longer plasma-derived factor VII half-life may explain their long lasting prophylactic effect
Keywords: pdFVII; Plasma-derived factor VII; rFVIIa; Recombinant activated factor VII; FVII; Factor VII; NCA; Non-Compartmental Analysis; OCA; One-Compartmental Analysis; Hb; Hemoglobin; T½; Half-life; Cmax; Peak plasma concentration of a drug after administration
Internal Mammary Artery Harvesting Influences Antibiotic Penetration Into Presternal Tissue
Keywords: ACT; time of aortic cross clamp; AUC; area under the concentration curve; BMI; body mass index; BUN; blood urea nitrogen; CABG; coronary artery bypass grafting; Cmax; maximum drug concentration; CO; cardiac output; CPB; cardiopulmonary bypass; DSWI; deep
Laparoendoscopic Single Site Reconstructive Procedures in Urology: Medium Term Results
Keywords: laparoscopy; endoscopy; reconstructive surgical procedures; LESS; laparoendoscopic single site surgery; LOS; length of stay; R-LESS; robotic laparoendoscopic single site surgery; T½; half-life; UTI; urinary tract infections;
Chenodeoxycholate in Females With Irritable Bowel Syndrome-Constipation: A Pharmacodynamic and Pharmacogenetic Analysis
Keywords: Bile Acid; 7αC4; FGF19; FGFR4; AC; ascending; ANCOVA; analysis of covariance; BMI; body mass index; CDC; (sodium) chenodeoxycholate; CF6; colonic filling at 6 hours; FGF19; fibroblast growth factor 19; FGFR4; fibroblast growth factor receptor 4; GC; geom